Trends in drug-resistant tuberculosis in National Higashisaitama Hospital, 1994-2001

Kekkaku

Volumn 78, Issue 2, 2003, Pages 83-87

  Yonemaru, Makoto ^a   Toyoda, Takeo ^b   Shirai, Tetsu ^a   Haga, Takayuki ^a   Shiomi, Tetsuya ^a   Suzuki, Tsuneo ^a   Kawashiro, Takeo ^a  

^a Higashisaitama National Hospital   (Japan)

^b NONE

Author keywords

Acquired resistance; Drug resistant tuberculosis; Multiple drug resistant tuberculosis; Primary resistance; Resistance ratio

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; HOSPITAL; HOSPITAL PATIENT; HUMAN; JAPAN; MULTIDRUG RESISTANCE; PREVALENCE; TUBERCULOSIS;

HUMANS; JAPAN; PREVALENCE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0344211827     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Abe C, Hirano K, Wada M, et al.: Resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan, 1997. Int J Tuberc Lung Dis. 2001; 5: 46-52.
2. Hirano K, Kazumi Y, Abe C, et al.: Resistance to anti-tuberculosis drugs in Japan, Tubercle Lung Dis. 1996; 77: 130-135.
3. Moore M, Onorato I, McCray E, et al.: Trends in drug-resistant tuberculosis in the United States, 1993-1996. JAMA. 1997; 278:833-837.
4. Weis S, Slocum P, Blais F, et al.: The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis, N Engl J Med. 1994; 330: 1179-1184.